This joint-focused formula provides clinical levels of glucosamine, boswellia extract, and 2,000 IU of Vitamin D3 to support physical mobility as one ages. These nutrients target structural drivers of aging like joint flexibility and bone mineral density, which are critical for maintaining independence.
The inclusion of 5-Loxin boswellia ensures a high potency of the active AKBA compound for managing age-related inflammatory markers. While restorative for structural health, the tablet delivery format lacks the lipid medium necessary for optimal Vitamin D uptake.